Status:
TERMINATED
Sublingual Immunotherapy for Food Allergy
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Food Allergies
Eligibility:
All Genders
4+ years
Phase:
NA
Brief Summary
The questions proposed by this study are those of safety and efficacy. 1. Concerning safety: "Are sublingual food drops (SLIT) safe enough to be used for stimulation of natural immune suppression in ...
Detailed Description
Design: Randomized-controlled blinded trial to evaluate the safety and efficacy of sublingual immunotherapy for food allergy sufferers. The study will report any adverse events caused by the administ...
Eligibility Criteria
Inclusion
- Chronic, reproducible symptoms following meals.
- Multiple food allergies where dietary avoidance is nearly impossible.
- Patients age 4 and older.
- Testing to verify food allergies is positive.
Exclusion
- History of anaphylaxis, angioedema, asthma, or life-endangering reactions to certain food products.
- Children under the age of 4.
- Previous attempts to treat food allergy (subcutaneous injections).
- General medical condition that precludes elective therapy (including pregnancy).
- Inability to follow food allergy SLIT regimen.
- Autoimmune Disease.
- Chronic use of steroids.
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00736281
Start Date
October 1 2008
End Date
June 1 2016
Last Update
June 17 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital: Department of Otolaryngology - Head and Neck Surgery
Columbia, Missouri, United States, 65212